Rats undergo a period in early postnatal development during which they exhibit a reduced response to stress (stress-hyporesponsive period, SHRP). SHRP is marked by a reduced capacity to secrete adrenocorticotropin (ACTH) and corticosterone in response to stressful stimuli. To characterize pituitary responsiveness during this period, we examined the release of ACTH from cultured pituitary cells derived from rats at different ages. Corticotrophs were studied from animals before (day 1 postnatally), during (days 6 and 11) and after (days 16, 20 and adult) SHRP. Direct stimulation of dispersed pituitary cells, with increasing concentrations of synthetic corticotropin-releasing factor (CRF; 1 × 10–12 to 1 × 10–8M), produced significant ACTH release at all ages tested. The greatest maximal release was observed for cells isolated from animals at 6 and 11 days of age (in the midst of SHRP). CRF-stimulated ACTH release from cells obtained just prior to (day 1) or immediately following (days 16 and 20) the hyporesponsive period was dramatically reduced (relative to cells from adult animals). SHRP is, therefore, not due to diminished intrinsic corticotroph responsiveness. In fact, pituitary cells derived from animals in SHRP exhibited enhanced ACTH secretion relative to cells from animals outside SHRP. This enhanced secretion was manifested as both an increased basal (unstimulated) release of ACTH as well as an increased maximal release of ACTH at saturating concentrations of CRF.

Keywords:
Stress response, Neonatal, Adrenocorticotropin, Corticotropin-releasing factor, Developmental neuroendocrinology
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.